29. Hall M. T., Simms K. T., Lew J. B., Smith M. A., Brotherton J. M., Saville M., Frazer I. H., Canfell K. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
30. Chow EPF. 90 % Reduction in genital warts in Australia. Presented at 32nd Annual International Papillomavirus Conference, October 2018, Sydney, Australia. Available at: https://kirby.unsw.edu.au/news/90-decline-genital-warts-young-australians. Accessed May 5, 2019.
31. Burchell A. N., Coutlée F., Tellier P. P., Hanley J., Franco E. L. Genital transmission of human papillomavirus in recently formed heterosexual couples.
32. Centers for Disease Control and Prevention. 2008 through 2017 adolescent HPV vaccination coverage trend report. Available at: https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/hpv/trend/index.html. Accessed May 4, 2019.
33. Oliver S. E., Unger E. R., Lewis R., McDaniel D., Gargano J. W., Steinau M., Markowitz L. E. Prevalence of human papillomavirus among females after vaccine introduction-National Health and Nutrition Examination Survey, United States, 2003–2014.
34. McClung N. M., Gargano J. W., Park I. U., et al. Estimated number of cases of high-grade cervical lesions diagnosed among women – United States, 2008 and 2016.
35. Andersson L. RETRACTED: increased incidence of cervical cancer in Sweden: possible link with HPV vaccination.
36. Motta M., Callaghan T., Sylvester S. Knowing less but presuming more: Dunning-Kruger effects and the endorsement of anti-vaccine policy attitudes.
37. Betsch C., Renkewitz F., Betsch T., Ulshöfer C. The Influence of Vaccine-critical Websites on Perceiving Vaccination Risks.
38. Ogilvie G. S., Phan F., Pedersen H. N., Dobson S. R., Naus M., Saewyc E. M. Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003–2013).